AS Medication Solutions, a drug repackage company, announced today that all Caraco brand digoxin 0.25mg tablets, distributed prior to March 31, 2009, which are not expired and are within the expiration date of August, 2011, are being voluntarily recalled to the consumer level. This action follows Caraco Pharmaceutical Laboratories’ March 31, 2009 nationwide recall that was made because the digoxin tablets may differ in size and therefore could have more or less of the active ingredient. The recalled product is a scored, round, biconvex tablet imprinted with “441,” with an NDC number of 54569-5758-0 (30-count). Consumers with the recalled product should return these tablets to their pharmacy or place of purchase.
Digoxin is indicated for the treatment of mild-to-moderate heart failure (with a diuretic and an ACE inhibitor when possible) and for control of ventricular response rate in chronic atrial fibrillation.
For more information visit www.fda.gov/Safety/Recalls/ArchiveRecalls/ucm150734.htm.